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Surgical resection and survival of patients with
unsuspected single node positive lung cancer (NSCLC)
invading the descending aorta
Chirurgische Therapie und Überleben von Patienten mit Lungenkrebs
(NSCLC), tumoröser Invasion der Aorta descendens und nicht
vorbekannter solitärer Lymphknotenmetastase
Abstract
Background: Surgical treatment of non-small cell lung cancer (NSCLC)
with aortic invasion is still debated.
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Methods: Thirteen patients with locally advanced (T4) NSCLC and inva-
sion of the descending aorta underwent pneumonectomy (n=9) or Francesco Zaraca
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1 lobectomy(n=4)togetherwithaortaenblocresectionandreconstruction
(n=8) or subadventitial dissection (n=5), complete lymph node dissec- Steffen Decker
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tion, and had microscopic unsuspected node metastasis at N1 (n=5)
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and N2/3 (n=8) levels of whom 12 received radiation therapy. Clamp-
and-sew was used to resect and reconstruct the aorta. Heinrich Ebner
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Results: Operative mortality and morbidity rate was 0% and 23%, re-
spectively. Four patients died of systemic tumor relapse and 2 of local
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recurrence.Sixpatientswerealiveafteramedianfollow-upof40months
(range 15–125 months). Overall 5-year survival rate was 45%. Median
survival time and 5-year survival rate of patients after aortic resection
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was 35 months and 67%, respectively, and was 17 months and 0%,
respectively, after aortic subadventi-tial dissection (p=0.001). N1 and
Generale Regionale Di
Bolzano, Italy N2nodalstatusadverselyaffectedsurvival,butsurvivaldifferencewas
notsignificant(N1versusN2/3;52%versus39%at5years;p=0.998).
Conclusions: Aortic resection with single station node positive T4 lung
cancer can achieve long-term survival. The data indicate that aortic re-
section-reconstruction is associated with better outcome than subad-
ventitial dissection.
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Zusammenfassung
Hintergrund:DiechirurgischeBehandlungnicht-kleinzelligerLungentu-
more mit Aortawandinvasion wird kontrovers diskutiert.
Methoden:13Patientenmitlokalfortgeschrittenem(T4)nicht-kleinzel-
ligen Lungencarcinom, tumoröser Invasion der Aorta descendens und
präoperativ negativem N-Staging wurden in kurativer Intention primär
operiert. Operative Prozeduren: Pneumonektomie 8-mal, Lobektomie
4-malinKombinationmitsegmentalaortaleren-bloc-Resektion„clamp-
and-sew“ in 8 Fällen oder subadventitieller Aortawanddissektion in 5
Fällen und systematischer Lymphknotendissektion. 12 Patienten mit
definitivsolitärer,mikroskopischerLymphknotenmetastaseinN1-(n=5)
oder N2-Position (n=8) erhielten eine adjuvante Radiotherapie.
Ergebnisse: Die Krankenhaus-, resp. 90-Tage-Mortalität betrug 0%, die
Morbidität23%.ImweiterenVerlaufverstarben4Patientenandissemi-
nierter Metastasierung und 2 Patienten am lokalen Tumorrezidiv. Bei
einem mittleren Nachbeobachtungszeitraum von 40 Monaten leben
noch 6 Patienten (15–125 Monate). Die kumulativ prospektive 5-Jah-
resüberlebensrate der 13 Patienten betrug 45%. Die mittlere Überle-
1/9 GMS Thoracic Surgical Science 2009, Vol. 6, ISSN 1862-4006
Research Article OPEN ACCESSbenszeit und 5-Jahresüberlebensrate nach Aortaresektion betrug 35
Monate und 67%, nach Aortawanddissektion respektive 17 Monate
und 0% (p=0,001). Der N1- und N2/3-Lymphknotenstatus beeinträch-
tigten das Langzeitüberleben (N1 versus N2/3; 52% versus 39% nach
5 Jahren). Der Überlebensunterschied erreichte kein Signifikanzniveau
(p=0,998).
Schlussfolgerungen: Bei einer lokal fortgeschrittenen Lungenkrebser-
krankung ist in ausgewählten Fällen, auch bei Vorliegen einer solitären
Lymphknotenmetastase, mit einer primären, erweiterten Resektions-
therapie ein Langzeitüberleben erzielbar. Nach unseren Ergebnissen
istbeiumschriebeneraortalerInfiltrationderaortalenen-bloc-Resektion
gegenüber der subadventitiellen Aortawanddissektion der Vorzug zu
geben. Weitere Studien sollten den Nutzen multimodaler Therapiekon-
zepte evaluieren.
Schlüsselwörter: Lungenkrebsoperation, Aortaresektion, Off pump,
Ergebnisse
Introduction
Initial reports of extended resections required for lung
cancerwithinfiltrationofadjacentorganstructureswere
associated with high rates of incomplete resection con-
siderable morbidity and mortality and poor long-term
outcome [1], [2]. Newer data has yielded promising sur-
vivalratesbetween30%and40%,ifnomediastinallymph
node metastases are present and complete resection is
achieved [3], [4]. However, recent series has provided
25% up to 40% long-term survival data of resected pa-
tients with multiple and single node unsuspected N2
disease [5]. Various resection techniques have been re-
fined for locally advanced (T4) tumors, mostly non-small
celllungcancer(NSCLC)withinvasionofthecarina,vena
cavaandspine[6].RegardingT4tumors,predominantely
N2 NSCLC with aortic invasion few reports exist [7], [8],
[9], [10], [11], [12], [13], [14], [15], [16], [17] with limited
numbers of patients which were treated with different
therapeutic regimens. The studies vary for surgical tech-
nique and use of bypass adjuncts, and reveal non-homo-
geneous early outcome and survival (Table 1).
Inthispaperwediscussthesurgicaloutcomesofpatients
withN1unsuspectedN2T4NSCLCandaorticinvolvement
according to distinct surgical procedures of aorta resec-
tion-reconstruction and subadventitial dissection.
Patients and methods
Between 1993 and 2005 thirteen patients underwent
extended resection of locally advanced lung cancer with
aortic involvement, and were retrospectively reviewed.
The patients were given a clinical diagnosis of a primary
NSCLCoftheleftupperlobe(n=12)andlower-lobe(n=1).
Aorticinfiltration(clinicalT4)wasdiagnosedwithachest
computed tomographic scan (Figure 1).
All patients underwent a bone scan, abdominal CT ima-
ging, and magnetic resonance or CT imaging of the head
to rule out distant metastasis. Absence of mediastinal
lymphadenopathywasdiagnosedwhenlymphnodeshad
a short diameter of less than 1.0 cm on the CT image,
and was histologically confirmed by performing staging
mediastinoscopy.Positronemissiontomography(PET-CT)
has become available at our institution only at the end
of 2006. PET-CT, just as thoracoscopy or thoracotomy,
were not used for the staging of the T and N status;
whereas EBUS, EUS-FNA were accidentally used for sus-
picious targets detected on CT scan. Selection criteria
included patients less than 70 years of age without sig-
nificant cardiac disease (echo, stress-echo), renal dis-
orders, or considerable co-morbidities, and a predicted
post-operative FEV1 more than 40% by perfusion scan
in combination with pulmonary function tests. Written
informed consent was obtained from all patients based
on the current surgical results and risks of extended
surgery for T4 lung cancer, in particular of aortic surgical
repair.
Operative techniques
The operative approach was an axillary anterior thora-
cotomy. The pericardium was completely incised around
the hilar vessels. Posteriorly, the pericardiotomy was ex-
tended upward to an U-shaped hilar release. The des-
cending aorta was encircled with a tape just below the
aortic tumor adherence. Anteriorly the ductus arteriosus
was divided giving access to the aortic arch, which was
laid free and encircled with a tape between the origin of
the left carotid and subclavian artery. Absence of tumor
invasion of the carotid arteries and the thoracic spine
below spine level Th 9 indicated that resection could be
carried out without the use of a bypass support. Initially
thelungresectionaseitherpneumonectomyorlobectomy
was performed in a standard fashion. The bronchus was
cutandclosedbysimpleinterruptedsuturesof4-0vicryl,
followed by nodal dissection (levels 7, 10, 4, and 9) in-
cluding N1 nodes, where appropriate for the surgical
procedure; whereas nodal stations 5, 6, 8 were removed
together with the tumor, thus processing a complete
lymph node dissection. Full exposure of the tumor and
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Figure 1: (A) Chest computed tomographic (CT) scan at the level (Th V) of the descending aorta, demonstrating aortic invasion
(arrow) of a centrally located tumor. (B) The CT scan of the level of six thoracic vertebra shows a tumor abutting the descending
aorta (arrow) .
adherent aorta was obtained by traction of the detached
lung towards the thoracotomy (Figure 2).
When the aortic infiltration was locally confined to the
adventitiaandaplaneofdissectionwithintheaorticwall
could easily be developed, a subadventitial dissection
was conducted (Figure 3A). Otherwise, when invasion of
the aortic media was evident or suspected, and more
than approximately 30% of aortic circumference was in-
volved by the tumor, tubular aortic resection was per-
formed (Figure 3B).
Beginningatthesiteoftheanticipatedproximalanastom-
osis,theaortawasmobilisedcircumferentially.Intercostal
arteries were exposed and clipped to the distal margins
oftheaortictumoradherence.Atthispoint100%oxygen,
fullheparinizationandpermissivemoderatehypotension
were started. Next the aorta was cross-clamped, divided
and extracted en bloc with resected lung. The aorta was
replaced with a primary patent prosthetic graft using a
continuous 3-0 polypropylene suture for anastomotic re-
pair. Finally the bronchus was covered with viable neigh-
bouring tissue.
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of the aortic media (arrow).
The left lower lobe (LLL) is detached. The left upper lobe (LUL)
is in situ and anastomosed by double sleeve (not shown).
Figure 3: Operative view. (A) Tumor removed from the
descending aorta by subadventitial dissection (arrow).
(B) Graft replacement of the descending aorta (arrow); lung
removed. Bronchus (Br) cut and closed by manual sutures.
Statistical methods
The primary end point of the study was postoperative
death from any cause following surgery or the last follow-
up visit. Patient survival was analysed with the date of
thoracotomy as the starting point using life-table esti-
mates by the method of Kaplan-Meier. Differences
between the curves when comparing the groups were
tested for significance using log-rank statistics. A p-value
of less than or equal to 0.05 was considered significant.
Results
The clinical and pathological characteristics of the 13
cases are depicted in Table 2.
Most patients were male, with a mean age of 62 years
(range 49 to 69 years). Surgical procedures included 9
pneumonectomies, 3 upper lobectomies, and one lower
lobectomy together with aorta resection-reconstruction
(case 1–8) or aortic subad-ventitial dissection (case
9–13). Ten patients underwent concurrent bifurcation
plasty (n=5), partial resection of the oesophagus muscle
wall (n=4), and double sleeve (n=1). Histologically, the
tumors consisted of adenocarcinoma (n=7), squamous
cell carcinoma (n=4), and undifferentiated carcinoma
(n=2). No important differences were noted concerning
age, sex, histologic assessment, pathologic N status, or
adjuvanttherapyamongaortaprocedurerelatedgroups.
Of the 13 patients, who were clinically diagnosed N0–1,
5 pathologically revealed N1 and 7 unsuspected N2 or
N3 in one. The N2, N3 nodes were found fixed to the
tumor, and were only discovered at the time of histologic
examination of the operative specimen. The nodes were
limited to a single node or station, and were related to 5,
8L, 8R stations. That highlightens the clinical problem of
preoperative differentiation between a centrally located
tumor and immediate adjacent or clearly involved nodal
disease which even intraoperatively – given that an en
bloc resection is performed rather than a discontinuous
resection – may be impossible; and finally explains that
in this study accuracy of clinical N-factor only reached
poor 38%. On the other hand, of the 13 patients who
were diagnosed clinical T4, 11 had pathologic confirm-
ationofT4(histologicevidenceoftumorwithintheaortic
wall), 7 (64%) with invasion of the media. The accuracy
of clinical T factor was 85%.
Resection was complete in 11 (85%) patients including
patientswithtubularaorticresection.Althoughresection
wasconsideredcompletebyintraoperativefrozensection,
in 2 (15%) of the dissection patients resection was ultim-
atelyincompletesincealymphatictumorcellpropagation
microscopicallywasfoundattheaorticresectionmargin.
Radiationtherapywasadministeredtoallbutonepatient
with N1 or N2/3 disease because of the suggestion that
this decreases local tumor recurrence.
Theoperativecharacteristicsofthe8patientswhounder-
went aortic resection and graft replacement are set out
in Table 3.
Clamp times were 20 to 32 minutes (average, 24
minutes). The patients were extubated after an average
of 1 day (range, 0 to 3 days). No perioperative complica-
tions due to aortic clamping were noted. In particular
spinalcordinjuryaseitherparaplegiaorparaparesiswas
notobserved.Noearlydeathsoccured.Therewerethree
majorcomplicationsin2patientsincludingpostoperative
bleeding (n=2) and late chylothorax (n=1), and were
successfullytreatedbyVATS(video-assistedthoracoscop-
ic surgery). The other patients had no postoperative
complications and recovered uneventfully. Average stay
in the intensive care unit was 8 days (range 7 to 10 days)
and in hospital was 27 days (range 23 to 32 days). The
inhospitalrespective90-days-mortalityratewas0%,and
the morbidity rate was 23%.
Follow-up was completed for all patients in 8 to 125
months (average 36 months). Four patients died of sys-
temic metastasis and 2 died of local recurrence within
35monthsoftheoperation.Inaddition,onepatientdied
of unknown reason 62 months after resection therapy.
Six patients were alive after a median follow-up of 40
months(range15–125months)withtwoabsolute5-year
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Table 3: Operative characteristics of the 8 patients who underwent resection and reconstruction for T4 lung cancer
survivors. The median survival time of the 13 patients
was 28 months and the overall 5-year survival rate was
45%. The median survival time and 5-years survival rate
were48monthsand67%,respectively,forthe8patients
withaorticresection/reconstruction,and17monthsand
0%, respectively, for the 5 patients with aortic dissection
(p=0.001, Figure 4) favoring aortic resection. The differ-
ences in survival between patients with complete or in-
completeresection(p=0.198)failedtoreachsignificance,
due to the small numbers of patients in each group. On
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Wex et al.: Surgical resection and survival of patients with unsuspected ...Figure 4: Survival of patients after aortic resection (n=8; solid line) and subadventitial dissection (n=5; dotted line) for T4 lung
cancer with aortic involvement. There was a significant difference in the 5-year survival rate (p=0.001).
Figure 5: Survival of patients with T4 non small cell lung cancer invading the thoracic aorta, grouped by nodal status.
The 5 year survival rate were 52% and 39% for N1 and N2/N3, respectively (p=0.998).
the basis of pathological N factor the overall 5-year sur-
vival rate was 52% for patients with pathological N1 and
39% for patients with pathological N2 or N3 (p=0.998,
Figure 5), underlining the adverse implications N2 and
N1 disease had on survival. Eighty percent of patients
with aortic dissections (Table 4) had either local recur-
rence or systemic recurrent disease.
Bycontrast,25%ofaorticresectionpatientshadsystemic
relapse. Summarizing, N1–2 disease, recurrence, and
6/9 GMS Thoracic Surgical Science 2009, Vol. 6, ISSN 1862-4006
Wex et al.: Surgical resection and survival of patients with unsuspected ...mode of resection had obvious implications on survival
outcome.
Table 4: Recurrence
Comment
Resection of the aorta in combination with resection of
N2 lung cancer has been considered of unproven thera-
peutic value since the oncologic results of such surgery
were disappointing [18]. According to a literature review
(Table 1) approximately 100 patients underwent aortic
resections with T4, mostly N2 primary lung cancer as
were included in distinct therapeutic regimens (adjuvant
chemo-/radiotherapy and induction chemotherapy). In
these series the overall postoperative mortality ranged
from 0 to 12.5%. However, pooling different types of
aortic resections (resection/reconstruction and subad-
ventitialdissection;bypasssupport,crossclamp),reveals
non-homogeneous outcome and long-term survival.
Theinvolvementoftheaortainfluencesthetypeofresec-
tion. Aortic invasion can be suspected when the tumor is
inappositiontotheaortaandthefatplaneislostbetween
theaortaandthetumor[19].Theinvasionmaybelimited
to the adventitia, but more commonly the media will also
be invaded. When present resection requires cross-
clamping to remove the infiltrated wall. On technical as-
pects using a CPB or a shunt prothesis may facilitate re-
section [12], [16], and in case of aortic arch involvement
willmaintainperfusionoftheupperandlowerpartofthe
body during cross-clamping in order to prevent spinal
cord ischemia and renal failure [12]. However, former
resultsofsurgeryfordescendingthoracicaorticaneurysm
repair [20], [21] provided support for our thesis that
clamp and sew aortic resection with T4 lung cancer and
limited invasion to the descending aorta is feasible with
alowincidenceofcomplications.Sincespinalcordinjury
isthesinglemostdevastatingcomplication,itsoccurence
is particularly likely in repair of the peridiaphragmatic
aorta[22].Fromthisareaspinalcordvesselsmostlyarise
inparticularthearteryofAdamkiewiczbetweenTh8and
L 1 in up to 91% [23], [24]. Consequently we restricted
aortic resection to the above Th 8 spine area. Average 5
intercostal arteries were sacrificed less than are judged
critical for cord perfusion [22]. Due to our operative
strategy which encloses lung resection at first step fol-
lowed by aortic resection-reconstruction, we were able
to minimize aortic occlusion time to or less than 30
minutes; thus reducing the risk of spinal cord injury and
other critical complications [20], [21], [25].
Nodaldiseasecompromiseslong-termoutcome[9],[10],
[12], [13], [15] and limits survival by tumor relapse.
Therefore it has been claimed that operative indication
should be restricted to patients who were diagnosed
clinical N0/1 [10]. Whereas chemotherapy, most likely
initsneoadiuvantformhasbeenadministeredtopatients
with clinical N2 disease [15] and, was proposed [17] or
demanded [12] for pathological N2. Mediastinal lymph-
adenopathywasdiagnosedasclinicalN2,whenthelymph
node had a short diameter of greater than 1.0 cm on the
CT image [15], or was confirmed pathological N2 by per-
forming mediastinoscopy [10], [17]. Scarce information
is available regarding clear up of immediate adjacent or
clearly tumor involved nodes in particular of paraaortic,
subaortic, and periesophageal nodes. These nodes rep-
resent regional disease (adjacent nodal metastases) of
a centrally tumor with aortic invasion. The high numbers
of unsuspected (nonimaged) N2 nodes in this study and
unsettled (imaged) N2 disease in others is a glaring
problem and may have been the result of an incomplete
or inadequate pretherapy staging of the mediastinum.
Another explanation is that because the series extend
over long periods, modern diagnostic techniques (video-
endoscopy;PETmodalities;EBUSandEUS-FNA)werenot
available or were applied only exclusively at that time.
Today, there is a strong demand for improved application
of staging modalities, as is critical for selecting patients
that may most benefit from an operation. However, we
must be aware that the quality of staging frequently is
limited for cases in which: (1) direct video-endoscopic
access to subcarinal node, and para-/subaortic or peri-
oesophageal node might be prohibited by extension of
the tumor itself; (2) identification of regional disease
(adjacent mediastinal nodal metastasis) using PET scan
modalitiescanbeconfoundedbytheintensehypermeta-
bolic activity of a centrally located tumor [26]; (3) the
routine use of EBUS or EUS-FNA without suspicious tar-
getsonPETandCTscansforN2isunsafe[5];andfinally,
(4)surgicalexplorationasastagingtooltoselectpatients
withpotentiallyresectable,clinicallystagedT4N0-1lung
cancermayleadtoariskyandunfavorablediscontinuous
dissection of lung and aorta tumor structures, disre-
garding that in our opinion the surgeon should be able
to evaluate the possibility of a radical resection before
thoracotomy.
Given that even a “thorough” staging will not ultimately
predict mediastinal N2 disease distinct multimodality
treatment regimens disclosed a way out this dilemma:
patients with a T4 NSCLC infiltrating the aorta, and with
CT matched lymphadenopathy as clinical N2 disease
showedafterinductionchemotherapyamarkedreduction
oflymphadenopathyandnometastasisonpostoperative
histologic examination. That indicated a possible down-
staging in 7 out of 10 patients after therapy, and was
associated with 5-year survivals of 70% for patients with
N0 and 16.7%, respectively, for patients with persistent
N2 or N3 disease [15]; alternatively, patients with T1-4
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pected N2 disease who underwent complete resection,
and were followed by adiuvant therapy (chemotherapy
and radiotherapy), had 5-year survivals of 35% to 40%
[5] which is at least threefold better than the average
number oncologists quote for N2 disease. Although the
studiesarehardlycomparableforseveralaspects,never-
theless the results obtained let us firmly believe that for
a given heterogeneity of N2 disease patients may profit
from a certain multimodality treatment concept and that
there is a place of primary surgery for accurate staged
limited N2 disease. However, as there is not at all clear
that preoperative chemotherapy is actually better than
postoperativechemotherapyfurtherstudiesareneeded.
Asaffectingourcurrentpracticeandbasedonourresults
we suggest the following treatment algorithm. Patients
with a T4 tumor infiltrating the aorta, as confirmed by CT
imaging,shouldroutinelyundergoPET-CTandmediastino-
scopy, and further examinations, such as EUS-FNA or
EBUS for suspicious targets identified by both CT scan
and PET-CT. Patients who are N2 positive will get induc-
tion chemotherapy. Those N2 negatives will get a radical
lung and aortic en bloc resection and systematic lymph
node dissection. Patients with unsuspected N2 disease
willhaveadjuvantchemotherapy,andincaseofextracap-
sular or multistation N2 disease radiotherapy is added.
Outcome is adversely affected by incomplete resection
and recurrence [9], [12]. There is strong evidence that
completeresectioncanhavemorefavorableresults[15],
[17]. Two of our initial patients (case 9, 10) who under-
went subadventitial aortic dissections had local tumor
recurrences about 5 and 10 months after the operation.
Wesuspectedthatlocalrecurrencewasduetolymphatic
tumor cell propagation beyond the aortic adventitia. Fur-
thermorewespeculatedthataorticdissection,evenwhen
proven a complete resection by intraoperative frozen
section,failstoreachonefundamentalsofradicalcancer
surgery, i.e. resect at a distance of the tumor. That is why
such a “shaving” procedure reflects a borderline poten-
tiallyendolesionalresectioninpatientswithevenminimal
aorticinvolvementand,fromasurgicalpointofview,risks
a marginal, discontinuous and incomplete resection. In
contrast to that radical en bloc resection of the tumor
and invaded aorta has the uppermost potential for work
out complete resection. Another 4 patients had systemic
tumor relapse as a result of N1/2 disease. No patient
withincompleteresectionandlocalrecurrence,systemic
relapse, or had aortic subadventitial dissection survived
more than 3 years. The most important results of this
studyderivedlong-termsurvivalanalysis.TheN2andN1
disease had obvious adverse implications on survival.
Actually, single station N2 disease was found to have a
much better prognosis than can be expected for more
extended N2 disease. Consequently, it comes down to
patientselectionforwhichmostaccuratestaging,atleast
with PET-CT and mediastinoscopy is a precondition. Not
surprisingly, patients’ survivals after complete aortic re-
section-reconstruction were found to be 67% at 5 years,
with 2 patients surviving more than 5 years, which was
significantly better than that of aortic dissection patients
(p=0.001), and is identical with a 70% 5-year survival of
patients with preoperative chemotherapy reported by
Ohta and colleagues [15].
In conclusion our results indicate that primary surgery is
justified in selected patients with single station N2 non-
small cell lung cancer and invasion of the descending
aorta.Thereareclearlymanylegitimatewaystocarryout
such a complex operation. However, clamp-and-sew is
aneffectivemeansofrepairofthedescendingaortawith
a calculated risk of spinal cord dysfunction. The data
suggestthataorticresection-reconstructionisassociated
with better outcome than subadventitial dissection. Fur-
ther studies should address the appropriate surgical
technique and medical therapy whether preoperative
chemotherapyultimatelyimprovesoutcomeandsurvival,
or is postoperative chemotherapy prefered.
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